Search

everythinglearnresearchcommunity

for

Search:↓

New compounds were found to help increase hair growth and decrease hair loss.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

Skin aging is caused by stem cell damage and can potentially be delayed with treatments like antioxidants and stem cell therapy.

An 81-year-old man's white hair began to regain its original color while he was treated with lenalidomide, suggesting that graying hair might be reversible.

Cyclodextrins improve how steroid drugs work and are used in marketed medications and environmental applications.

New acne treatments show promise as alternatives to traditional therapies.

Lack or blocking of SRD5a, a key component in hormone creation, can lead to conditions like pseudohermaphrodism and affect hair growth, bone mass, muscle strength, and reproductive health. More research is needed on its regulation from fertilization to adulthood.

The 2018 update to the ED care model added a new severity score and stressed a detailed evaluation of both physical and psychological aspects.

Topical minoxidil helps treat female pattern hair loss, but more research needed for other treatments.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Adrenal gland disease is common in ferrets and causes hair loss and other symptoms.

Unwanted facial hair significantly impacts over 40% of women's psychological and social well-being, and various treatment options are available.

Southeast Asian herbs show promise for skin and hair care, but more research is needed to confirm their effectiveness in cosmetics.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Vitamin D boosts a specific gene activity in kidney cells that could improve heart and kidney function.

Advanced therapies like gene, cell, and tissue engineering show promise for hair regrowth in alopecia, but their safety and effectiveness need more verification.

Various treatments, including FDA-approved drugs, natural products, and oral supplements, can help with hair loss, but a patient's medical history and potential allergies should be considered when choosing a treatment.

Alfacalcidiol and metformin together lowered testosterone in women with PCOS, but did not significantly improve acne, hair growth, or pregnancy rates.

Liposomes improve the delivery and effectiveness of cosmetic ingredients but face challenges like cost and stability.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

The leaf extract of Leea indica may reduce inflammation, dissolve blood clots, and promote hair growth.

Combination therapy with oral contraceptives and spironolactone improves hair growth, menstrual issues, and acne in women with PCOS.

Women with PCOS-related infertility can often conceive with treatments like clomiphene and metformin, but managing pregnancy complications is important.

Researchers found that most genes affecting drug responses are not fully covered by commercial SNP chips, suggesting the need for more comprehensive tools to optimize drug selection based on genetics.

Early treatment and lifestyle changes are important for managing PCOS in young people to prevent long-term health issues.

New hair loss treatments may include topical medications, injections, and improved transplant methods.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Metformin effectively improves metabolic symptoms in women with PCOS, while alfacalcidiol does not have a significant impact.

Mitochondrial therapy and platelet-rich plasma therapy both stimulated hair regrowth in aging mice, with mitochondrial therapy showing similar effectiveness to plasma therapy.

Method measures latanoprost and minoxidil in skin accurately and precisely.